Cytisine as an alternative smoking cessation product for Pacific smokers in New Zealand

V. Nosa, Kotalo Leau, Natalie Walker
{"title":"Cytisine as an alternative smoking cessation product for Pacific smokers in New Zealand","authors":"V. Nosa, Kotalo Leau, Natalie Walker","doi":"10.26635/phd.2018.919","DOIUrl":null,"url":null,"abstract":"ABSTRACT \nIntroduction: Pacific people in New Zealand have one of the highest rates of smoking.  Cytisine is a plant-based alkaloid that has proven efficacy, effectiveness and safety compared to a placebo and nicotine replacement therapy (NRT) for smoking cessation.  Cytisine, like varenicline, is a partial agonist of nicotinic acetylcholine receptors, and blocks the rewarding effects of nicotine. Cytisine is naturally found in some plants in the Pacific region, and so may appeal to Pacific smokers wanting to quit. This paper investigates the acceptability of cytisine as a smoking cessation product for Pacific smokers in New Zealand, using a qualitative study design. \nMethods: In December 2015, advertisements and snowball sampling was used to recruit four Pacific smokers and three Pacific smoking cessation specialists in Auckland, New Zealand. Semi-structured interviews where undertaken, whereby participants were asked about motivations to quit and their views on smoking cessation products, including cytisine (which is currently unavailable in New Zealand). Interviews were recorded and transcribed verbatim, with thematic analysis conducted manually. \nFindings: Pacific smokers reported wanting to quit for loved ones and family, but did not find currently available smoking cessation products effective. Almost all participants had not previously heard of cytisine, but many of the Pacific smokers were keen to try it. Participants identified with cytisine on a cultural basis (given its natural status), but noted that their use would be determined by the efficacy of the medicine, its cost, side-effects, and accessibility. They were particularly interested in cytisine being made available in liquid form, which could be added to a “smoothie” or drunk as a “traditional tea”.  Participants thought cytisine should be promoted in a culturally-appropriate way, with packaging and advertising designed to appeal to Pacific smokers. \nConclusions: Cytisine is more acceptable to Pacific smokers than other smoking cessation products, because of their cultural practices of traditional medicine and the natural product status of cytisine.","PeriodicalId":82251,"journal":{"name":"Pacific health dialog","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pacific health dialog","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26635/phd.2018.919","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ABSTRACT Introduction: Pacific people in New Zealand have one of the highest rates of smoking.  Cytisine is a plant-based alkaloid that has proven efficacy, effectiveness and safety compared to a placebo and nicotine replacement therapy (NRT) for smoking cessation.  Cytisine, like varenicline, is a partial agonist of nicotinic acetylcholine receptors, and blocks the rewarding effects of nicotine. Cytisine is naturally found in some plants in the Pacific region, and so may appeal to Pacific smokers wanting to quit. This paper investigates the acceptability of cytisine as a smoking cessation product for Pacific smokers in New Zealand, using a qualitative study design. Methods: In December 2015, advertisements and snowball sampling was used to recruit four Pacific smokers and three Pacific smoking cessation specialists in Auckland, New Zealand. Semi-structured interviews where undertaken, whereby participants were asked about motivations to quit and their views on smoking cessation products, including cytisine (which is currently unavailable in New Zealand). Interviews were recorded and transcribed verbatim, with thematic analysis conducted manually. Findings: Pacific smokers reported wanting to quit for loved ones and family, but did not find currently available smoking cessation products effective. Almost all participants had not previously heard of cytisine, but many of the Pacific smokers were keen to try it. Participants identified with cytisine on a cultural basis (given its natural status), but noted that their use would be determined by the efficacy of the medicine, its cost, side-effects, and accessibility. They were particularly interested in cytisine being made available in liquid form, which could be added to a “smoothie” or drunk as a “traditional tea”.  Participants thought cytisine should be promoted in a culturally-appropriate way, with packaging and advertising designed to appeal to Pacific smokers. Conclusions: Cytisine is more acceptable to Pacific smokers than other smoking cessation products, because of their cultural practices of traditional medicine and the natural product status of cytisine.
Cytisine作为新西兰太平洋地区吸烟者的替代戒烟产品
摘要简介:新西兰是太平洋地区吸烟率最高的国家之一。Cytisine是一种植物生物碱,与安慰剂和尼古丁替代疗法(NRT)相比,已被证明具有戒烟的疗效、有效性和安全性。Cytisine和varenicline一样,是烟碱乙酰胆碱受体的部分激动剂,可以阻断尼古丁的奖励作用。Cytisine天然存在于太平洋地区的一些植物中,因此可能会吸引想要戒烟的太平洋吸烟者。本文采用定性研究设计,调查了胞嘧啶作为新西兰太平洋吸烟者戒烟产品的可接受性。方法:2015年12月,在新西兰奥克兰,采用广告和雪球抽样的方法招募了四名太平洋吸烟者和三名太平洋戒烟专家。进行半结构化访谈,询问参与者戒烟的动机以及他们对戒烟产品的看法,包括胞苷(目前在新西兰没有)。访谈被逐字记录和转录,并由人工进行专题分析。调查结果:太平洋地区的吸烟者报告说,他们想为亲人和家人戒烟,但没有发现目前可用的戒烟产品有效。几乎所有参与者以前都没有听说过胞苷,但许多太平洋地区的吸烟者都热衷于尝试它。参与者在文化基础上(鉴于其自然状态)认同胞苷,但指出其使用将取决于药物的疗效、成本、副作用和可及性。他们对以液体形式提供胞嘧啶特别感兴趣,胞嘧啶可以添加到“奶昔”中,也可以作为“传统茶”饮用。参与者认为应该以符合文化的方式推广胞嘧啶,包装和广告旨在吸引太平洋地区的吸烟者。结论:Cytisine比其他戒烟产品更容易被太平洋吸烟者接受,这是因为他们的传统医学文化实践和Cytisine的天然产物地位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信